Company Performance - Tvardi Therapeutics, Inc. (NASDAQ: TVRD) experienced an 84.23% decline in stock price, dropping to $6.56 from a year high of $43.65, possibly due to updates on its Phase 2 REVERT clinical trial for idiopathic pulmonary fibrosis [1][7] - Brag House Holdings, Inc. (NASDAQ: TBH) saw a 53.33% decrease to $1.12, down from a year high of $6.96, which may be linked to its recent merger with House of Doge [2][7] - Defiance Daily Target 2x Short QBTS ETF (QBTZ) recorded a 48.32% drop to $11.37, reflecting broader market trends or specific sector movements in the quantum computing industry [3][7] - Beyond Meat, Inc. (NASDAQ: BYND) faced a 46.57% decline to $1.074, down from a high of $6.81, potentially due to its announcement of an exchange offer for Convertible Senior Notes [4][7] - Enlightify Inc. (NYSE: ENFY) saw a 40.90% fall to $0.43, down from a year high of $2.53, as it informed the NYSE of its intent to address a price deficiency [5] Market Trends - The recent price declines across various sectors highlight market volatility and the diverse factors influencing investor sentiment, including company-specific challenges and broader economic conditions [6][7]